This is an excellent point of discussion.
It's pretty clear that Novartis is gone cold on MSB and are giving MSB the silent treatment.
Meanwhile, MSB waits forlornly for the call, the AFR continues to regularly publish interesting news articles to keep MSB in the limelight.
Growing doubt on COVID-19 Application, page-9
-
- There are more pages in this discussion • 4,726 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
-0.018(1.71%) |
Mkt cap ! $1.164B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | $1.01 | $2.255M | 2.199M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 245299 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 162500 | 20 |
View Market Depth
| Last trade - 11.26am 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |